返回 Agenda
Session Chair(s)
Jan Geissler, MBA
Managing Director
Patvocates, Germany
Matthias Gottwald
Head R&D Policy and Networking
Bayer Pharma AG, Germany
Speaker(s)
The Patient’s View
Alastair Kent, MHS
Genetic Alliance UK, United Kingdom
Co-Chair of the UK Rare Disease Policy Board; Former Executive Director
The Industry View
Anton Hoos, MD, PHD, MBA
Patient Focused Medicine Development, Belgium
Executive Team
The Regulator View
Birka Lehmann, MD
University of Bonn, Germany
Patient Expert